| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 135.36× | 135.36× | 117.97× | — | 129.85× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.92× | 1.14× | 1.96× | — | 1.77× | ||
| 0.30× | 0.30× | 0.35× | 0.34× | 0.30× | ||
| −0.41× | −0.41× | −0.49× | 3.99× | 8.86× | ||
| −0.49× | −0.49× | −0.74× | 0.82× | 1.32× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 129.85 | — | 117.97 | 135.36 | 135.36 | |
| Working Capital Turnover | 1.77 | — | 1.96 | 1.14 | 0.92 | |
| Asset Turnover | 0.30 | 0.34 | 0.35 | 0.30 | 0.30 | |
| Cash Conversion (CFO/Net Income) | 8.86 | 3.99 | -0.49 | -0.41 | -0.41 | |
| CFO/EBITDA | 1.32 | 0.82 | -0.74 | -0.49 | -0.49 |